EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Advanced Risk Stratification in Non-Ischemic Cardiomyopathy: The Prognostic Role of Cardiac Magnetic Resonance

Guido Pastorini iD, Marzia Testa, Eleonora Indolfi iD, Enrica Conte, Fabio Anastasio iD, Mauro Feola iD

Journal of Clinical Medicine · 20.01.2026 · 15 (2) · 841

DOI: 10.3390/jcm15020841 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 20.01.2026. Verfasst von Guido Pastorini und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Division, Ospedale Regina Montis Regalis Strada del Rocchetto 99, ASLCN1, 12084 Mondovi, Italy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiac magnetic resonance (CMR) imaging has been considered crucial in non-ischemic cardiomyopathy (NICM). This study aims to evaluate the role of CMR in identifying risk factors for life-threatening events in patients with NICM and reduced left ventricular ejection fraction (LVEF).

Methods

We analysed 57 (mean age 62.5 ± 11.4 years, 68.4% male) first-diagnosed NICM patients with reduced LVEF (mean 42 ± 9%). CMR assessments evaluated LVEF, right ventricular ejection fraction (RVEF), cardiac T1 mapping, extracellular volume (ECV), and the presence/extension of late gadolinium enhancement (LGE). Patients were monitored for a composite endpoint including sudden cardiac death (SCD), major ventricular arrhythmic events, and hospitalization for heart failure (HHF).

Results

During a median follow-up lasting 543 days, 18 patients (31%) experienced cardiovascular events. A higher native T1 mapping value (1076 (1025–1120) ms vs. 999 (990–1037) ms, p < 0.001), a higher ECV (34 ± 6% vs. 28 ± 4,% p < 0.001) and a reduced RVEF (52 ± 13% vs. 60 ± 9%, p < 0.03) proved to be significantly correlated to an increased HHF, arrhythmic and SCD risk. Additionally, a native T1 mapping value exceeding 1018 ms demonstrated an increased risk (HR: 6.285; 95% CI: 2.044–19.326, p = 0.001) as well as an ECV greater than 28% (HR: 19.752; 95% CI: 2.622–148.817, p = 0.004) for composite endpoint.

Conclusion

In NICM patients, elevated native T1 mapping and ECV values identified a high-risk subgroup for arrhythmic events while LVEF, and RVEF provide further risk stratification for the composite endpoint. CMR assessment may optimize risk stratification in NICM patients.

Schlagwörter

Stichwörter der Autor:innen

cardiac magnetic resonancemappingnon-ischemic cardiomyopathy

Autor:innen und Institutionen

  • Cardiology Division, Ospedale Regina Montis Regalis Strada del Rocchetto 99, ASLCN1, 12084 Mondovi, Italy.
  • Cardiology Division, Ospedale Dario Camberlingo, ASL, 72017 Brindisi, Italy.
  • Cardiovascular Rehabilitation, Ospedale Fossano ASLCN1, 12045 Fossano, Italy.

ORCID-Profile: Guido Pastorini, Eleonora Indolfi, Fabio Anastasio, Mauro Feola

Zitieren

APA

Pastorini, G., Testa, M., Indolfi, E., Conte, E., Anastasio, F., & Feola, M. (2026). Advanced Risk Stratification in Non-Ischemic Cardiomyopathy: The Prognostic Role of Cardiac Magnetic Resonance. Journal of Clinical Medicine, 15(2), 841. https://doi.org/10.3390/jcm15020841

Vancouver

Pastorini G, Testa M, Indolfi E, Conte E, Anastasio F, Feola M. Advanced Risk Stratification in Non-Ischemic Cardiomyopathy: The Prognostic Role of Cardiac Magnetic Resonance. Journal of Clinical Medicine. 2026;15(2):841. doi:10.3390/jcm15020841

BibTeX
@article{Pastorini2026,
  author = {Pastorini, Guido and Testa, Marzia and Indolfi, Eleonora and Conte, Enrica and Anastasio, Fabio and Feola, Mauro},
  title = {Advanced Risk Stratification in Non-Ischemic Cardiomyopathy: The Prognostic Role of Cardiac Magnetic Resonance},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {2},
  pages = {841},
  doi = {10.3390/jcm15020841}
}
Kostenlos starten →